You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride and what is the scope of patent protection?

Calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride is the generic ingredient in five branded drugs marketed by Abbott, Hospira, B Braun, Epic Pharma Llc, Alcon, and Baxter Hlthcare, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE

US Patents and Regulatory Information for CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare PLASMA-LYTE R IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium lactate INJECTABLE;INJECTION 017438-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Abbott TPN ELECTROLYTES IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride INJECTABLE;INJECTION 019399-001 Jun 16, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
B Braun ISOLYTE E IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium citrate INJECTABLE;INJECTION 019718-001 Sep 29, 1989 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Select Pharmaceutical Salts

Last updated: February 20, 2026

What Are the Current Market Drivers?

The market for pharmaceutical-grade salts including calcium chloride, magnesium chloride, potassium chloride, sodium acetate, and sodium chloride is influenced by multiple factors:

  • Rising healthcare demand: Aging populations and chronic disease prevalence increase demand for electrolyte and fluid replacement therapies.
  • Regulatory standards: Stringent quality and safety standards for pharmaceutical-grade salts drive adoption and manufacturing costs.
  • Manufacturing capacity: Expansion in chemical manufacturing plants, especially in Asia-Pacific, enhances supply chain resilience.
  • Generic drug proliferation: Increased production of generic formulations utilizing these salts lowers costs and widens market reach.
  • Research and development: Ongoing clinical studies exploring novel uses expand indications and market applications.

Market Size and Forecast

Compound Global Market Size (2022) Projected CAGR (2023-2028) Key Applications
Calcium chloride $400 million 3.8% Electrolyte replenishment, cardiac care
Magnesium chloride $250 million 4.2% Magnesium deficiency treatment, dialysis
Potassium chloride $1.2 billion 5.1% Electrolyte balance, cardiac therapy
Sodium acetate $180 million 2.9% Buffer solutions, dialysis solutions
Sodium chloride $3.5 billion 3.5% Hydration therapy, IV fluids

The overall global electrolyte and saline solution market exceeding $5 billion in 2022 is expected to grow at approximately 3.9% annually through 2028.

Industry Supply Chain and Manufacturing Trends

  • Consolidation: Industry players like Baxter, Fresenius, and Grifols dominate production, benefiting from integration.
  • Raw material sourcing: Dependence on natural mineral extraction and salt evaporation ponds influences costs.
  • Quality standards: Good Manufacturing Practices (GMP) requirement for pharmaceuticals increases compliance costs but ensures higher product quality.
  • Innovation: Development of specialized formulations (e.g., premixed IV solutions) enhances market differentiation.

Pricing Dynamics

Pricing varies based on:

  • Purity and certification: Grades like USP or EP fetch premiums.
  • Supply chain disruptions: Raw material shortages or geopolitical tensions elevate costs.
  • Regulatory compliance: Stringent approvals can delay market entry, affecting pricing strategies.

Average prices per kilogram (2022):

Compound Approximate Price ($/kg)
Calcium chloride $4.50 - $6.50
Magnesium chloride $6.00 - $8.00
Potassium chloride $3.00 - $5.00
Sodium acetate $2.50 - $4.00
Sodium chloride $0.50 - $1.00

Higher-grade pharmaceuticals command premium prices over bulk or industrial grades.

Competitive Landscape

Major companies focus on scale and quality:

  • BASF: Leading producer for several salts with global supply capabilities.
  • Fresenius: Focuses on high-purity, ready-to-use IV solutions.
  • American National Salt: Supplies bulk commodities primarily for industrial uses but expanding into pharma.

Niche manufacturers target specific indications or novel delivery formats.

Regulatory and Market Barriers

  • Approval processes: Registering new formulations entails lengthy clinical and quality assessments.
  • Pricing pressure: Buyers push for price reductions amid widespread generic competition.
  • Import/export restrictions: Variations in tariffs and standards impact global trade flows.

Investment and R&D Outlook

The focus on electrolyte management in critical care and dialysis creates growth opportunities. Expansion into developing markets delivers long-term revenue, while technological innovations, such as stability-enhanced formulations, open additional revenue streams.

Key Takeaways

  • The pharmaceutical salts market exhibits steady growth driven by rising healthcare needs and technological advances.
  • Potassium chloride dominates market value, with an CAGR of over 5% forecasted through 2028.
  • Price competition and regulatory burdens shape profitability, favoring large-scale entrants with GMP-certified products.
  • Supply chain stability and raw material costs directly influence pricing and margins.
  • Innovation in formulation and delivery methods supports market expansion and differentiation.

FAQs

1. Which compound has the highest market value?
Sodium chloride leads the market at approximately $3.5 billion in 2022.

2. What is the primary application for magnesium chloride?
Magnesium deficiency treatment and dialysis are key applications.

3. How do regulatory standards affect market growth?
GMP and other standards increase compliance costs but improve product quality, influencing market entry and pricing.

4. What factors influence pricing fluctuations?
Raw material costs, purity grade, supply chain disruptions, and regulatory compliance impact prices.

5. What future trends will shape this market?
Continued R&D, market expansion into emerging economies, and technological innovations in delivery and formulations.


References

[1] IndustryARC. (2022). Pharmaceutical Salts Market - Global Opportunity Analysis and Industry Forecast, 2023-2028.
[2] Fact.MR. (2023). Electrolyte Market Size and Forecast.
[3] MarketsandMarkets. (2022). IV Solutions Market - Global Forecast to 2028.
[4] U.S. Food and Drug Administration. (2022). Guidelines for Pharmaceutical-grade Salt Production.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.